Member Info for Ctw2014

Exactly.

Third day on the trot they are playing dirty, putting a low couple of small trades through at the end of the day to exaggerate the headline apparent drop, presumably in a feeble attempt to panic a few more into selling. Zeeez

Technick - I agree that the AIHL test is a quicker test but in the interview he did say the new test could be done “within an hour or that sort of time frame”. I don’t know about you, but looking again at that interview David seemed really relaxed and confident (almost smug but not quite). I really do think we will get an announcement following this up, pretty soon: “The Company is also actively seeking development partners, distributors and non dilutive funding to support the most rapid development possible”. I also loved the casual reference to “the World Health Organisation called this week”. It’s clear to me that Genedrive is looking at playing a significant global role in all this and are being taken very seriously. I previously posted a link to the MRC COVID Rapid Response Fund scheme which we know they applied to and we agree that a grant from that source is pretty likely. DYOR

Results in under an hour I believe. Results on the AIHL test are available in 27 minutes.

And it’s Liverpool not Leeds, sorry.

By the way, that 90,000 tests figure is the UK only!

Yes a really good interview which should give punters new to the Company a clearer idea of Genedrive’s approach on coronavirus testing but also, it’s contract with the US Dept of Defence and the test for antibiotic related hearing loss In babies. Just for context, I was informed back in 2017 that the Genedrive handheld test instrument was priced then at about £4000 per unit. So, 500 units at £4K is obviously £2million, which is significant for a company of Genedrive’s size. Then on top of that are the test cartridges themselves to be used with the instruments. On the anti biotic related hearing loss test, there is a potential of about 90,0000 tests per annum and, at a test price of £60, that could generate an income of £5.4 million pa. In my view the NHS is almost certain to adopt the Genedrive system for this and the company is gearing up for a GLOBAL launch. The trial at Manchester and a Leeds is an IMPLEMENTATION trial, the test itself is already proven and approved for use. The trial was originally scheduled to complete in May but may obviously be delayed somewhat given the impact of the current crisis (although I doubt by much, given the benefits to babies and NHS budgets). Then there is the HCV test, the TB test in development oh, and of course now the Coronavirus tests, as well as potentially many more in due course. No one trick pony this, and loads of potential given the small market cap and limited shares in issue. Not advice and please DYOR

Expected news but great to get the confirmation. Some will not have been expecting this until later today or Monday, given that the key meeting was supposed to have been today. Onwards and upwards from here. Off take agreements soon I suspect.

Cheers Sirius. Your right about the average, but there is a limit to how much I will put into any one share and, unfortunately, I reached it with this one. My basic problem has been timing. I got in much too early. You are also right about the time lines of the majority who got in on the news, although I suspect a fair few are now under water and trapped to a degree. I am confident I will see profit again as you say, maybe when you say, but I also think there is a fair chance it could be sooner, on news of non dilutive funding, or a partnership. GL.

Oh look, another big trade at a thumping great premium dropped in just after close. MMS did the same thing yesterday, with a bit more subtlety, and fooled me into thinking we would get a rise first thing. I am not going to be fooled this time. Not that it matters. I am in this for the long haul (been in since 2015 and averaged down regularly to the extent that yesterday got me into the black albeit not for long). The Coronavirus tests are great, but there is an investment case at this level, even without them, in my opinion at least. That’s not advice of course. Pl DYOR

Exactly. For example, in the UK alone, there is the potential for 90,000 tests pa for antibiotic related hearing loss in babies. GDR’s test for that at .£60 a pop could therefore generate £5.4 million pa for the a Company, just for that test, and just in the UK! Please DYOR

Oh, and ignore the SP currently showing too as that’s way out of date. Equally useless!

Baldy, the last four trades of the day give you a pretty big clue what’s going to happen first thing, in my opinion:
16.32 - 60,000 bought at 30p for £18,000
16.32 - 50,000 bought at 30p for £16,250
16.33 - 50,000 bought at 30p for £15,000
These were amongst the largest trades of the day. And then....
16.39 - 5,000 bought at 37p (note price hike) for £1,850
Now, I offer no advice, draw your own conclusions, but I know what I think will happen first thing! GL
DYOR
By the way, if you want to verify those trades you will need to look elsewhere as this site seems to have given up on printing trades at 13.37. Useless!

They have been delaying trades of any size for a while, pushed the live prices down a lot to scare people, and now it’s bouncing back up, if you check live prices and ignore what they want you to think

MMs delaying all trades as far as I can see, not just big ones.

Pushed the price right down, delayed trades imo, to attract sells. But live sell price moving back up fast.

And some big buyers beginning to appear now

Suggest you google the above. My guess is we will get an announcement of an award from this next but no advice given. Please do your own research.

Cheers - nice to be popular!

...and still looking strong. Still only a £10m market cap - compare that to other similar companies